Key Financials
| in Mio. € (in €) | 2025 | 20241,2 | 20232 | 20222 | 2021 |
|---|---|---|---|---|---|
| Business development | |||||
| Order intake | 354.3 | 423.7 | 420.5 | 411.0 | 337.0 |
| Order book as of December 31 | 266.8 | 428.9 | 452.5 | 335.4 | 193.9 |
| Sales | 503.2 | 446.7 | 304.3 | 260.0 | 263.4 |
| Gross profit | 179.4 | 176.8 | 103.9 | 100.6 | 94.2 |
| Gross profit margin | 35.7% | 39.6% | 34.1% | 38.7% | 35.8% |
| Cost of sales | 323.8 | 269.8 | 200.4 | 159.3 | 169.2 |
| Research and development costs | 47.0 | 40.0 | 31.3 | 28.7 | 22.1 |
| EBITDA | 77.7 | 82.4 | 34.7 | 37.4 | 29.6 |
| EBITDA margin | 15.4% | 18.4% | 11.4% | 14.4% | 11.2% |
| EBIT | 65.9 | 75.1 | 27.8 | 31.5 | 22.6 |
| EBIT margin | 13.1% | 16.8% | 9.1% | 12.1% | 8.6% |
| Earnings after taxes (continuing operations) | 49.5 | 52.1 | 17.3 | 23.3 | 16.0 |
| Earnings per share, basic (in EUR) continuing operations3 | 2.41 | 2.72 | 0.91 | 1.22 | 0.86 |
| Balance Sheet and Cash Flow | |||||
| Equity | 315.5 | 283.1 | 176.6 | 177.7 | 156.9 |
| Equity ratio | 62.2% | 56.6% | 47.8% | 50.3% | 56.2% |
| ROCE | 21.3% | 36.8% | 17.5% | 23.6% | 14.0% |
| Balance sheet total | 507.4 | 499.8 | 369.7 | 353.2 | 279.2 |
| Net Cash | 49.1 | 122.9 | 32.8 | 41.3 | 33.8 |
| Free cash flow (continuing operations) | −26.0 | 95.4 | 7.9 | 17.0 | 14.7 |
| Further Key Figures | |||||
| Investments | 23.2 | 7.6 | 4.6 | 4.1 | 9.6 |
| Investment ratio | 4.6% | 1.7% | 1.5% | 1.6% | 3.6% |
| Depreciation | 11.8 | 7.8 | 6.9 | 5.9 | 7.1 |
| Employees as of December 31 (FTE) | 1,497 | 1,498 | 1,207 | 1,091 | 1,178 |
| 1 Figures adjusted; see Section D of the Notes to the Consolidated Financial Statements 2 Without MicroOptics segment 3 Adjusted for the contribution of SUSS MicroOptics S.A. | |||||